Wells Fargo
EVO icon

Wells Fargo’s Evotec EVO Stock Holding History

Wells Fargo’s Portfolio EVO Stock Details EVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4
Closed -$13 – 7208
2025
Q1 		$13 Buy
+4
New +$16 ﹤0.01% 6740
2022
Q3 		– Sell
-5,500
Closed -$66K – 6834
2022
Q2 		$66K Buy
5,500
+1,500
+38% +$19.6K ﹤0.01% 4877
2022
Q1 		$61K Buy
4,000
+2,998
+299% +$51.3K ﹤0.01% 5555
2021
Q4 		$24K Buy
+1,002
New +$23.3K ﹤0.01% 6269

Other funds holding EVO

MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
P
Pitcairn Conshohocken, Pennsylvania $1.27B AUM 23.64% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Wells Fargo's EVO Position: Q2 2025 in Review

Wells Fargo sold out of Evotec (EVO) in Q2 2025, closing a stake of 4 shares — an estimated $13 sold.

Wells Fargo first reported a position in EVO in Q4 2021 and held it in 4 quarters. The position peaked at $66K in Q2 2022. 37 funds tracked by Wall St. Rank hold EVO as of Q2 2025.

  • Wells Fargo reported no remaining Evotec position as of Q2 2025 after selling out during the quarter.
  • Wells Fargo sold 4 Evotec shares in Q2 2025, an estimated $13.
  • Wells Fargo first reported a position in Evotec in Q4 2021 and held it in 4 quarters.
  • Wells Fargo's Evotec position peaked at $66K in Q2 2022.
  • 37 funds tracked by Wall St. Rank held Evotec as of Q2 2025.

Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.